Kukje Pharma Co Ltd (002720) — Working Capital to Net Assets Ratio
Kukje Pharma Co Ltd (002720) has a Working Capital to Net Assets ratio of 11.9% as of September 2025. Working capital of ₩11.36 Billion (current assets of ₩72.45 Billion minus current liabilities of ₩61.09 Billion) is measured against net assets of ₩95.32 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Kukje Pharma Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Kukje Pharma Co Ltd Working Capital to Net Assets (2013–2024)
This chart shows how Kukje Pharma Co Ltd's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 11.9%, reflecting working capital of ₩11.36 Billion against net assets of ₩95.32 Billion KRW. See Kukje Pharma Co Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Kukje Pharma Co Ltd (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Kukje Pharma Co Ltd from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Kukje Pharma Co Ltd market cap and net worth.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 31.7% | ₩28.43 Billion | ₩89.55 Billion | ₩56.97 Billion | ₩28.55 Billion | ▲ +37.1 pp |
| 2023 | -5.4% | ₩-4.57 Billion | ₩84.95 Billion | ₩55.12 Billion | ₩59.69 Billion | ▼ -6.3 pp |
| 2022 | 0.9% | ₩680.31 Million | ₩74.08 Billion | ₩48.54 Billion | ₩47.86 Billion | ▲ +10.1 pp |
| 2021 | -9.2% | ₩-6.32 Billion | ₩68.59 Billion | ₩48.20 Billion | ₩54.52 Billion | ▼ -1.5 pp |
| 2020 | -7.7% | ₩-5.42 Billion | ₩70.50 Billion | ₩49.94 Billion | ₩55.36 Billion | ▼ -10.8 pp |
| 2019 | 3.1% | ₩1.88 Billion | ₩60.95 Billion | ₩61.14 Billion | ₩59.25 Billion | ▼ -6.2 pp |
| 2018 | 9.3% | ₩6.36 Billion | ₩68.70 Billion | ₩54.56 Billion | ₩48.20 Billion | ▼ -4.0 pp |
| 2017 | 13.2% | ₩8.96 Billion | ₩67.78 Billion | ₩59.54 Billion | ₩50.58 Billion | ▼ -2.3 pp |
| 2016 | 15.6% | ₩10.51 Billion | ₩67.52 Billion | ₩60.44 Billion | ₩49.93 Billion | ▼ -34.9 pp |
| 2015 | 50.4% | ₩34.52 Billion | ₩68.46 Billion | ₩66.56 Billion | ₩32.04 Billion | ▲ +18.3 pp |
| 2014 | 32.2% | ₩16.35 Billion | ₩50.85 Billion | ₩71.91 Billion | ₩55.56 Billion | ▼ -35.1 pp |
| 2013 | 67.2% | ₩39.23 Billion | ₩58.33 Billion | ₩70.31 Billion | ₩31.09 Billion | — |